Articles
🇺🇸 AmericasExpert insights, opinion pieces, and in-depth analysis on pharmaceutical trends and FDA regulations.
FDA Approval Gene Therapies: Market Analysis Post-Hemophilia Innovations
This article delves into the impact of FDA-approved gene therapies, focusing on Hemgenix for hemophilia and the evolving market landscape.
FDA Breakthrough Therapy Designations: Advancing Alzheimer's Drug Development
Learn how FDA Breakthrough Therapy Designations are transforming Alzheimer's drug development, focusing on innovative treatments like Aducanumab.
Master Protocols: How Platform Trials Are Revolutionizing Drug Development
Master Protocols are revolutionizing drug development by streamlining clinical trials for multiple indications, improving efficiency and patient outcomes.
KRAS Inhibitors for NSCLC: Complete Guide to Latest FDA Approvals 2024
Stay updated on the latest FDA approvals for KRAS inhibitors in non-small cell lung cancer (NSCLC), featuring key advancements and treatment options for patients.